Hahn B H, Gonda M A, Shaw G M, Popovic M, Hoxie J A, Gallo R C, Wong-Staal F
Proc Natl Acad Sci U S A. 1985 Jul;82(14):4813-7. doi: 10.1073/pnas.82.14.4813.
Converging lines of research have linked human T-cell lymphotropic virus type III (HTLV-III) to the pathogenesis of the acquired immune deficiency syndrome. A characteristic feature of this virus is its genomic heterogeneity, which occurs to varying degrees in different viral isolates. To define further the nature and extent of these genomic changes, we compared the molecularly cloned genomes of two variant HTLV-III isolates by extensive restriction enzyme mapping and heteroduplex thermal melt analysis. Both viral isolates were found to be highly related to each other throughout their entire genomic complement, yet they differed markedly in their restriction enzyme maps. Electron microscopic heteroduplex analysis revealed several distinct regions of divergence located almost exclusively in the part of the genome that encodes the viral envelope gene. In vitro culture of one of these viruses over a period of 3 months did not result in any genomic changes as determined by restriction analysis of viral DNA. These results, as well as the recently published nucleotide sequences of other HTLV-III isolates, indicate that the most substantial variation among HTLV-III isolates is located in the envelope. These findings raise the possibility that viral isolates from different individuals could have important biological differences in their envelope antigens, a consideration relevant to ongoing attempts to develop a vaccine against HTLV-III.
多项研究线索已将人类嗜T细胞病毒III型(HTLV - III)与获得性免疫缺陷综合征的发病机制联系起来。这种病毒的一个特征是其基因组的异质性,在不同的病毒分离株中其程度有所不同。为了进一步确定这些基因组变化的性质和程度,我们通过广泛的限制性酶切图谱分析和异源双链热变性分析,比较了两种变异型HTLV - III分离株的分子克隆基因组。发现这两种病毒分离株在其整个基因组组成上彼此高度相关,但它们的限制性酶切图谱却有显著差异。电子显微镜异源双链分析揭示了几个明显的差异区域,几乎完全位于编码病毒包膜基因的基因组部分。对其中一种病毒进行为期3个月的体外培养,通过对病毒DNA的限制性分析确定未导致任何基因组变化。这些结果以及最近发表的其他HTLV - III分离株的核苷酸序列表明,HTLV - III分离株之间最显著的变异位于包膜区。这些发现增加了一种可能性,即来自不同个体的病毒分离株在其包膜抗原方面可能存在重要的生物学差异,这一考虑与目前正在进行的开发抗HTLV - III疫苗的尝试相关。